Caspase-independent cell death revealed in human gastric cancer cell lines, MKN45 and KATO III treated with phenoxazine derivatives

Oncology Reports

Volumn 17, Issue 2, 2007, Pages 409-415

  Kasuga, Teruhiko ^a   Tabuchi, Takafumi ^a   Shirato, Ken ^b   Imaizumi, Kazuhiko ^b   Tomoda, Akio ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

Caspase independent apoptosis; Cell cycle arrest; Gastric cancer cells; Phenoxazines

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; DNA; OXAZINE DERIVATIVE; PHENOXAZINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL SURVIVAL; DOSE RESPONSE; HUMAN; IC 50; METABOLISM; NECROSIS; PATHOLOGY; STOMACH TUMOR; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INHIBITORY CONCENTRATION 50; MODELS, GENETIC; NECROSIS; OXAZINES; STOMACH NEOPLASMS; TIME FACTORS;

EID: 33947715741     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.2.409     Document Type: Article

References (30)

1. Crew KD and Neugut AI: Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362, 2006. (Pubitemid 43329250)
2. Smith MG, Hold GL, Tahara E and El-Omar EM: Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12: 2979-2990, 2006. (Pubitemid 43811073)
3. Osaki M, Tanabe S, Goto A, Hayashi H, Oshimura M and Ito H: 5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene. Apoptosis 2: 221-226, 1997. (Pubitemid 127505729)
4. Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, van Cutsem E, Planker M, Santos JG, Piedbois P, Paillot B, Bodensein H, Schmoll HJ, Bleiberg H, Nordlinger B, Couvreur ML, Baron B and Wils JA: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil and doxorubicin, versus etoposide, leucovorin and fluorouracil, versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 18: 2648-2657, 2000. (Pubitemid 30465650)
5. Barry MA, Behnke CA and Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990. (Pubitemid 20373997)
6. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998. (Pubitemid 28406816)
7. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998. (Pubitemid 28406817)
8. Brockman H, Bohnsack G and Franck B: Zur Konstitution der Actinomycine. Angew Chem 68: 70-71, 1956.
9. Hollstein U: Actinomycin. Chemistry and mechanism of action. Chem Rev 74: 625-652, 1974.
10. Motohashi N: Test for antitumor activities of phenothiazines and phenoxazines. Yakugaku Zasshi 103: 364-371, 1983.
11. Motohashi N, Mitshcer LA and Meyer R: Potential antitumor phenoxazines. Med Res Rev 11: 239-294, 1991.
12. Tomoda A, Arai S, Ishida R, Shimamoto T and Ohyashiki K: An improved method for the rapid preparation of a novel antitumor agent. Biorg Med Chem Lett 11: 1057-1058, 2002.
13. Shimizu S, Suzuki M, Tomoda A, Arai S, Taguchi H, Hanawa T and Kamiya S: Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria. Tohoku J Exp Med 203: 47-52, 2004. (Pubitemid 38832654)
14. Shimamoto T, Tomoda A, Ishida R and Ohyashiki K: Antitumor effects of novel phenoxazine derivative on human leukemia cell lines in vitro and in vivo. Clin Cancer Res 7: 704-708, 2001. (Pubitemid 32707997)
15. Abe A, Yamane M and Tomoda A: Prevention of growth of human lung carcinoma cells and induction of apoptosis by a novel phenoxazine, 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one. Anticancer Drugs 12: 377-381, 2001.
16. Shimizu S, Suzuki M, Miyazawa K, Yokoyama T, Ohyashiki K, Miyazaki K, Abe A and Tomoda A: Differentiation and apoptosis in human malignant melanoma G-361 cells induced by 2-amino-phenoxazine-3-one. Oncol Rep 14: 41-46, 2005.
17. Koshibu-Koizumi J, Akazawa M, Iwamoto T, Takasaki M, Mizuno F, Kobayashi R, Abe A, Tomoda A, Hamatake M and Ishida R: Antitumor activity of a phenoxazine compound, 2- amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: induction of mixed types of cell death, apoptosis, and necrosis. J Cancer Res Clin Oncol 128: 363-368, 2002. (Pubitemid 34824178)
18. Kato S, Shirato K, Imaizumi K, Toyoda H, Mizuguchi J, Odawara M, Che XF, Akiyama S, Abe A and Tomoda A: Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2. Oncol Rep 15: 843-848, 2006.
19. Mori H, Honda K, Ishida R, Nohira T and Tomoda A: Antitumor activity of 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one against Meth A tumor transplanted into BALB/c mice. Anticancer Drugs 11: 653-657, 2000.
20. Kurosaki N, Kurosaki Kasuga T, Shirato K, Endo T and Tomoda A: 2-Aminophenoxazine-3-one suppresses the growth of mouse malignant melanoma B16 cells transplanted into C57/B16Cr Slc mice. Biol Pharm Bull (In press).
21. Green D and Kroemer G: The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 8: 267-271, 1998. (Pubitemid 28310224)
22. Hail BZ Jr, Carter M, Konopleva and Andreeff M: Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis 11: 889-904, 2006.
23. Park S-Y, Cho S-J, Kwon H-C, Lee K-R, Rhee D-K and Pyo S: Caspase-independent cell death by allicin in human epithelial carcinoma cells: involvement of PKA. Cancer Lett 224: 123-132, 2005. (Pubitemid 40720373)
24. Nagamine M, Okumura T, Tanno S, Sawamukai M, Motomura W, Takahashi N and Kohgo Y: PPARÁ ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells. Cancer Sci 94: 338-343, 2003. (Pubitemid 36626365)
25. Lorenzo HK, Susin SA, Penninger J and Kroemer G: Apoptosis inducing factor (AIF): a phylogenetically old, capaseindependent effector of cell death. Cell Death Differ 6: 516-524, 1999. (Pubitemid 29292107)
26. Vande Velde C, Cizeu J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R and Greenberg AH: BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 20: 5454-5468, 2000. (Pubitemid 30482883)
27. Hong SJ, Dawson TM and Dawson VL: Nuclear and mitochondrial conversation in cell death: PAPP-1 and AIF signaling. Trends Pharmacol Sci 25: 259-264, 2004. (Pubitemid 38553828)
28. Tobey RA: Different drugs arrest cells at a number of distinct stages in G2. Nature 254: 245-247, 1975.
29. Sen S and D'Incarci M: Apoptosis: biochemical events and relevance to cancer thermotherapy. Fed Eur Biochem Soc 307: 122-1227, 1992.
30. Ishida R, Yamanaka S, Kawai H, Ito H, Iwai M, Nishizawa M, Hamatake M and Tomoda A: Antitumor activity of 2-amino-4,4α-dihydro-4α,7-dimethyl- 3H-phenoxazine-3-one, a novel phenoxazine derivative produced by the reaction of 2-amino-5-methylphenol with bovine hemoglobin. Anticancer Drugs 7: 591-595, 1996. (Pubitemid 26276351)